AXA Framlington Biotech Fund - R AccumulationRegister to Unlock Ratings |
Growth Of 1000 (GBP) | 31/03/2024 |
|
Annual Returns (GBP) | 31/03/2024 | |||||||
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 31/03 | |
Price Return | 9.66 | -6.42 | 19.35 | 32.74 | 3.39 | 3.77 | 1.82 | 4.54 |
+/- Category | -0.64 | 1.55 | -0.84 | 6.77 | 12.43 | 11.61 | 3.10 | 2.24 |
+/- Category Index | -5.53 | -4.57 | 2.65 | -0.19 | 3.10 | 1.31 | -5.51 | -3.95 |
% Rank in Category | 62 | 50 | 58 | 18 | 7 | 23 | 30 | 38 |
Trailing Returns (GBP) | 18/04/2024 | ||
Total Returns | +/- Category | +/- Category Index | |
1 Day | -0.73 | 0.13 | -0.42 |
1 Week | -3.32 | 0.94 | -1.00 |
1 Month | -4.24 | 1.64 | -0.04 |
3 Months | -2.50 | 0.61 | -6.36 |
6 Months | 4.53 | -2.61 | -4.22 |
YTD | -2.33 | 2.82 | -6.27 |
1 Year | -0.87 | 1.05 | -8.13 |
3 Years Annualised | 2.99 | 9.40 | -3.22 |
5 Years Annualised | 8.47 | 2.89 | -3.15 |
10 Years Annualised | 10.94 | 1.65 | -0.67 |
Category: Sector Equity Biotechnology | |||
Category Index: Morningstar Gbl Biotechnology NR USD |
Quarterly Returns (GBP) | 31/03/2024 | |||
Quarter 1 | Quarter 2 | Quarter 3 | Quarter 4 | |
2024 | 4.54 | - | - | - |
2023 | -4.01 | -1.03 | 0.17 | 7.00 |
2022 | -8.74 | -0.07 | 15.90 | -1.82 |
2021 | -6.26 | 8.05 | 5.36 | -3.12 |
2020 | 0.34 | 29.26 | -2.28 | 4.73 |
2019 | 16.13 | 0.06 | -9.05 | 12.94 |
|
Advertisement |